Market Share of Next-Generation Immunology Drugs Industry
The next-generation immunology drugs market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The market players are focusing on new product launches, R&D, and expansions to gain a competitive advantage. Some of the market's major players include AbbVie Inc., Amgen Inc., AstraZeneca, GlaxoSmithKline PLC, Novartis AG, and F. Hoffmann-La Roche AG.
Next-Generation Immunology Drugs Market Leaders
AbbVie
Novartis AG
GSK plc
Pfizer Inc.
Bristol-Myers Squibb Company
*Disclaimer: Major Players sorted in no particular order
